Acarix AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACARIX.ST research report →
Companywww.acarix.com
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
- CEO
- Aamir Mahmood
- IPO
- 2016
- Employees
- 8
- HQ
- Malmö, SE
Price Chart
Valuation
- Market Cap
- $302.73M
- P/E
- -7.39
- P/S
- 37.58
- P/B
- 8.55
- EV/EBITDA
- -7.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 65.62%
- Op Margin
- -526.78%
- Net Margin
- -530.88%
- ROE
- -106.02%
- ROIC
- -114.82%
Growth & Income
- Revenue
- $7.36M · 18.69%
- Net Income
- $-48,091,000 · 27.34%
- EPS
- $-0.04 · 40.61%
- Op Income
- $-48,012,000
- FCF YoY
- 23.51%
Performance & Tape
- 52W High
- $0.47
- 52W Low
- $0.22
- 50D MA
- $0.28
- 200D MA
- $0.29
- Beta
- 0.32
- Avg Volume
- 1.21M
Get TickerSpark's AI analysis on ACARIX.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ACARIX.ST Coverage
We haven't published any research on ACARIX.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACARIX.ST Report →